Abstract
The aim of this study was to investigate the influence of serotonin receptors 2A, 2C and 1A gene variants on lithium prophylactic efficacy in mood disorders. One hundred and twenty-four subjects affected by bipolar (n=102) and major depressive (n=22) disorder were followed prospectively for an average of 52 months and were typed for 5-HT2A (T102C: n=111, HTP: n=104), 5-HT2C (n=110) and 5-HT1A (n=61) variants. Both 5-HT2A and 5-HT2C variants were not associated with lithium outcome. Consideration of possible stratification effects like gender, polarity, family history, age at onset and duration of lithium treatment did not influence results. No 5-HT1A gene variant was identified. 5-HT2A and 2C variants are not, therefore, associated with lithium prophylactic efficacy in mood disorders.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antimanic Agents / adverse effects
-
Antimanic Agents / therapeutic use*
-
Bipolar Disorder / diagnosis
-
Bipolar Disorder / drug therapy
-
Bipolar Disorder / genetics*
-
Depressive Disorder, Major / diagnosis
-
Depressive Disorder, Major / drug therapy
-
Depressive Disorder, Major / genetics*
-
Female
-
Follow-Up Studies
-
Genetic Variation / genetics
-
Genotype
-
Humans
-
Lithium Carbonate / adverse effects
-
Lithium Carbonate / therapeutic use*
-
Male
-
Middle Aged
-
Receptor, Serotonin, 5-HT2A
-
Receptor, Serotonin, 5-HT2C
-
Receptors, Serotonin / drug effects
-
Receptors, Serotonin / genetics*
-
Receptors, Serotonin, 5-HT1
-
Retrospective Studies
-
Treatment Outcome
Substances
-
Antimanic Agents
-
Receptor, Serotonin, 5-HT2A
-
Receptor, Serotonin, 5-HT2C
-
Receptors, Serotonin
-
Receptors, Serotonin, 5-HT1
-
Lithium Carbonate